NCT06337617
- Conditions
- BRAF V600 Mutation Positive Melanoma
- Locations
-
- Novartis Shanghai, China
Clinical trial condition
BRAF V600 Mutation Positive Melanoma
Explore clinical trials studying BRAF V600 Mutation Positive Melanoma. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies